Ben Inker, Head of Asset Allocation at GMO, summarizes GMO and Jeremy Grantham's 45-year historical research on how factor leadership evolves during prolonged bear markets.
0:00 / 0:30exact quote · 30.3s
720p mp4 · rendered on demand · StarZero watermark
“In the first stage of bear markets, everything tends to go down the same, and if anything helps, it's quality. In the second phase, valuation tends to matter. That doesn't mean value stocks always outperform in the second phase. It is the stuff that has gotten really cheap starts to outperform. And then in the third phase, You can even start to see a change in sign where the really cheap stuff, even before the market has hit the bottom, can start to turn around.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
More from Ben Inker
Insight
Inker: Assuming an automatic illiquidity premium across private equity is dangerous
“This assumption that you get paid an illiquidity premium for anything that happens to be illiquid is I think dangerous. I think it is going to cause you not to be focused on the question of, all right, if I think this is about operational excellence, why do I …”
Ben InkerMar 30, 2020▶ 1:03:00Ben Inker – Value Investing at GMO (First Meeting, EP.17)
“There is very, very little volatility to the underlying fair value. It's about one percent a year. And yet the market has a volatility of 17. And that's a mismatch that says there must be some predictability to the market”
Ben InkerMar 30, 2020▶ 8:42Ben Inker – Value Investing at GMO (First Meeting, EP.17)
Insight
Inker: Stated Earnings and Book Value Are Poor Metrics for Business Models
“When we are analyzing these companies, we realize it's not just that we don't care about their book value anymore, but even their stated earnings turn out to be a lousy test of whether this is a good business model.”
Ben InkerMar 30, 2020▶ 24:43Ben Inker – Value Investing at GMO (First Meeting, EP.17)
PredictionOpen · timeframe Mar 2030
Inker: US Value Spread Suggests Value Stocks Will Win Over 5-10 Years
“Again, in the US, the value spread is significantly wider than normal, and that probably means value deserves to win over the next five to 10 years.”
Ben InkerMar 30, 2020▶ 33:05Ben Inker – Value Investing at GMO (First Meeting, EP.17)
Insight
Inker: SoftBank's Vision Fund proved capital alone cannot buy market dominance
“I think one of the things we have seen in the, in some of the trials of what's gone on with the Vision Fund is this basic idea that, well, we can determine who is going to be the winner here by throwing a ton of money at one of the competitors. And assuming th…”
Ben InkerMar 30, 2020▶ 40:45Ben Inker – Value Investing at GMO (First Meeting, EP.17)
AssertionSupported
Inker: US manufacturing productivity has been net negative since 2011
“Productivity growth has been net negative. We are less productive making stuff than we were in 2011.”
Ben InkerMar 30, 2020▶ 47:46Ben Inker – Value Investing at GMO (First Meeting, EP.17)
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 700 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.